{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:27:34Z","timestamp":1787563654924,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jneuroim.2022.577899","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T21:11:05Z","timestamp":1654204265000},"page":"577899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis"],"prefix":"10.1016","volume":"369","author":[{"given":"Yu","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577899_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"927","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2022.577899_bb0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jamaneurol.2016.2588","article-title":"Bortezomib treatment for patients with anti-N-methyl-D-aspartate receptor encephalitis","volume":"7310","author":"Behrendt","year":"2016","journal-title":"Jama Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ane.12723","article-title":"Risk factors for mortality in patients with anti-NMDA receptor encephalitis","volume":"1364","author":"Chi","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"611","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"712","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0030","first-page":"E2185","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"9219","author":"de Bruijn","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0035","first-page":"97","article-title":"Autoimmune limbic encephalitis","volume":"61","author":"Didelot","year":"2011","journal-title":"Future Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"744","author":"Dubey","year":"2017","journal-title":"Jama Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/0004-282x20170176","article-title":"Autoimmune encephalitis: a review of diagnosis and treatment","volume":"761","author":"Dutra","year":"2018","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","article-title":"Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations","volume":"2707","author":"Endres","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"741","author":"Finke","year":"2017","journal-title":"Jama Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2017.07.012","article-title":"Neurobiology of autoimmune encephalitis","volume":"48","author":"Fukata","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0065","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","article-title":"Analysis of relapses in anti-NMDAR encephalitis","volume":"7710","author":"Gabilondo","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0070","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus","volume":"8518","author":"Gaspard","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"1012","author":"Granerod","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"154","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12028-016-0370-7","article-title":"Autoimmune encephalitis at the neurological intensive care unit: etiologies, reasons for admission and survival","volume":"271","author":"Harutyunyan","year":"2017","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00835","article-title":"Risk factors for intensive care unit admission in patients with autoimmune encephalitis","volume":"8","author":"Harutyunyan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0095","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"3017","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0100","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis","volume":"709","author":"Kayser","year":"2013","journal-title":"Jama Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"121","author":"Lancaster","year":"2016","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens-pathogenesis, associated disorders and antibody testing","volume":"87","author":"Lancaster","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.0000000000002635","article-title":"Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort","volume":"8618","author":"Lee","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"134","author":"Lee","year":"2016","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0125","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00115-016-0235-5","article-title":"Autoantibody-associated autoimmune encephalitis and cerebellitis. Clinical presentation, diagnostic work-up and treatment","volume":"8712","author":"Lewerenz","year":"2016","journal-title":"Nervenarzt."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.pcl.2015.03.011","article-title":"Autoimmune Encephalopathies","volume":"623","author":"Lim","year":"2015","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0135","first-page":"392","article-title":"Diagnostic and therapeutic approach to autoimmune neurologic disorders","volume":"383","author":"Lopez-Chiriboga","year":"2018","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"3811","author":"Mandel-Brehm","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0145","first-page":"964","article-title":"A systematic review of the neuropsychological sequelae of people diagnosed with anti N-methyl-D-aspartate receptor encephalitis in the acute and chronic phases","volume":"338","author":"Nicolle","year":"2018","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"38810039","author":"Owen","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0160","first-page":"290","article-title":"Autoimmune epilepsy: the evolving science of neural autoimmunity and its impact on epilepsy management","volume":"383","author":"Quek","year":"2018","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jocn.2013.07.017","article-title":"Autoimmune encephalitis: recent updates and emerging challenges","volume":"215","author":"Ramanathan","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0170","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00415-019-09590-9","article-title":"The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis","volume":"2685","author":"Ramanathan","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0175","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00134-016-4504-3","article-title":"Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study","volume":"4212","author":"SepNet Critical Care Trials, G","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00115-014-4030-x","article-title":"Paraneoplastic neurological syndromes and autoimmune encephalitis","volume":"854","author":"Stich","year":"2014","journal-title":"Nervenarzt."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"122","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0190","first-page":"666","article-title":"Autoantibody-mediated encephalitis differential diagnosis in patients with impaired consciousness of unclear origin","volume":"11540","author":"Wandinger","year":"2018","journal-title":"Deutsches Arzteblatt International."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0195","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ene.12911","article-title":"Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in Southwest China","volume":"233","author":"Wang","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","volume":"1385","author":"Warren","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jneuroim.2022.577899_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/epi.16807","article-title":"Seizures in autoimmune encephalitis-a systematic review and quantitative synthesis","volume":"622","author":"Yeshokumar","year":"2021","journal-title":"Epilepsia."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:09Z","timestamp":1759048869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822000947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"alternative-id":["S0165572822000947"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577899","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577899"}}